Elevated levels of inflammatory markers, such as C-reactive protein, are well documented in people with depression. Few studies have examined whether the association between inflammation and depression is symptom specific, and differs according to antidepressant treatment. Using data from the English Longitudinal Study of Ageing (N = 5909), cross-sectional analyses revealed a significant dose-response association between C-reactive protein and the symptoms of fatigue (P < 0.001), restless sleep (P = 0.03), low energy (P = 0.02) and feeling depressed (P = 0.04), but not other symptoms. These associations were absent in users of anti-depressant medication. Our findings suggest the C-reactive proteindepression association is symptom-specific and modified by antidepressant treatment.
Introduction
Levels of inflammatory markers, such as C-reactive protein (CRP), are elevated in people with symptoms of depression, although this is not a universal observation (Valkanova et al., 2013) . In these studies, depression symptomology is commonly measured with an aggregate score of different symptoms which may mask symptom-specific effects (Valkanova et al., 2013) .
Initial analyses into specific symptoms of depression found a significant association between CRP levels with an increased risk that participants reported they had ''not accomplished much recently" and felt ''like giving up", but not ''often feeling nervous or stressed" (Wium-Andersen et al., 2013) . These analyses were not, however, mutually adjusted for other symptoms, so they could be attributed to either somatic (e.g., fatigue) or psychological symptoms (e.g., feelings of low self-worth). In a recent item-level analysis of the US National Health and Nutrition Examination Survey, investigators adjusted these associations for the effect of other depressive symptoms and found CRP was independently associated with somatic (e.g., reports of tiredness, lack of energy, sleep problems and lack of appetite) but not psychological symptoms of depression (e.g., reports of depressed mood, anhedonia, feelings of self-worth) (Jokela et al., 2016) .
We examined these relationships in the English Longitudinal Study of Ageing (ELSA), a population of older people in whom levels of inflammatory markers and the occurrence of depression tend to be higher. Additionally, given that antidepressant drug therapy can have an inflammation-lowering effect (Hannestad et al., 2011), we explore the link between inflammation and specific symptoms of depression according to the use of such medication.
Materials and methods

Participants
Initiated in 2002/03 when study members were 50 years of age or older, the ELSA is an on-going, biennial, nationally representative, multi-disciplinary prospective cohort study of older people (Steptoe et al., 2013) . Ethical approval was given by the National Research Ethics Service (MREC/01/2/91) and written informed consent obtained from all participants.
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